Skip to main content

News

2025-06-11
MASSPROT: supporting cancer research
Thanks to the HDx-MS technology recently deloped within the MASSPROT platform (Woluwé site), a team of researchers from UCLouvain and the University of Lille has just reached an important milestone in cancer research by developing a revolutionary new compound: LIBX-A401.